These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8609399)

  • 41. Suppression mediated by anergic CD4+ T cells requires stimulation by MHC-peptide complexes and can be induced in the presence of costimulation.
    Witzke O; Wheeler PR; Barbara JA; Gaspar MC; Morris And PJ; Wood KJ
    Transplantation; 2001 Aug; 72(3):369-76. PubMed ID: 11502963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The magnitude of TCR engagement is a critical predictor of T cell anergy or activation.
    Mirshahidi S; Ferris LC; Sadegh-Nasseri S
    J Immunol; 2004 May; 172(9):5346-55. PubMed ID: 15100274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anergy induction by dimeric TCR ligands.
    Appel H; Seth NP; Gauthier L; Wucherpfennig KW
    J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anergy in peripheral memory CD4(+) T cells induced by low avidity engagement of T cell receptor.
    Mirshahidi S; Huang CT; Sadegh-Nasseri S
    J Exp Med; 2001 Sep; 194(6):719-31. PubMed ID: 11560989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered peptide ligands and wild-type peptide induce indistinguishable responses of a human Th0 clone.
    van Bergen J; Koning F
    Eur J Immunol; 1998 Sep; 28(9):2801-8. PubMed ID: 9754567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "Anergy" of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype.
    Gajewski TF; Lancki DW; Stack R; Fitch FW
    J Exp Med; 1994 Feb; 179(2):481-91. PubMed ID: 8294862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential induction of the NF-AT complex during restimulation and the induction of T-cell anergy.
    Wotton D; Higgins JA; O'Hehir RE; Lamb JR; Lake RA
    Hum Immunol; 1995 Feb; 42(2):95-102. PubMed ID: 7744623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of T-cell activation or anergy determined by the combination of intensity and duration of T-cell receptor stimulation, and sequential induction in an individual cell.
    Yamamoto T; Hattori M; Yoshida T
    Immunology; 2007 Jul; 121(3):383-91. PubMed ID: 17376194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential antigen sensitivity and costimulatory requirements in human Th1 and Th2 antigen-specific CD4+ cells with similar TCR avidity.
    Holzer U; Kwok WW; Nepom GT; Buckner JH
    J Immunol; 2003 Feb; 170(3):1218-23. PubMed ID: 12538679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Th2 cell clonal anergy as a consequence of partial activation.
    Sloan-Lancaster J; Evavold BD; Allen PM
    J Exp Med; 1994 Oct; 180(4):1195-205. PubMed ID: 7931057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell receptor-independent CD4 signalling: CD4-MHC class II interactions regulate intracellular calcium and cyclic AMP.
    Zhou W; König R
    Cell Signal; 2003 Aug; 15(8):751-62. PubMed ID: 12781868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics.
    Appleman LJ; Tzachanis D; Grader-Beck T; van Puijenbroek AA; Boussiotis VA
    J Mol Med (Berl); 2001; 78(12):673-83. PubMed ID: 11434720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification.
    Nishimura Y; Chen YZ; Kanai T; Yokomizo H; Matsuoka T; Matsushita S
    Intern Med; 1998 Oct; 37(10):804-17. PubMed ID: 9840700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of peptide-induced CD4+ T cell anergy in vitro.
    Ryan KR; Evavold BD
    J Exp Med; 1998 Jan; 187(1):89-96. PubMed ID: 9419214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigen analogues as antagonists of the T cell receptor.
    Grey HM; Alexander J; Snoke K; Sette A; Ruppert J
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S47-50. PubMed ID: 8324951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands.
    Combadière B; Reis e Sousa C; Germain RN; Lenardo MJ
    J Exp Med; 1998 Feb; 187(3):349-55. PubMed ID: 9449715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigen-specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306-318.
    Falk K; Rötzschke O; Strominger JL
    Eur J Immunol; 2000 Oct; 30(10):3012-20. PubMed ID: 11069085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T-cell anergy induced by clonotype-specific antibodies: modulation of an autoreactive human T-cell clone in vitro.
    Steenbakkers PG; Boots AM; Rijnders AW
    Immunology; 1999 Apr; 96(4):586-94. PubMed ID: 10233745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct patient responses to activation of T-cells by free HER-2, G89 (777-789) and protected LRMK-linked HER-2, {AE-39 [p776 (Ava-774-788)], AE-47 [(Ava-776-788)] and AE-37[p776 (774-788)]} peptides could lead to development of personalized cancer vaccines.
    Li Y; Matsueda S; Efferson CL; Tsuda N; Kawano K; Gao H; Peoples GE; Ioannides CG
    Anticancer Res; 2009 Jan; 29(1):41-58. PubMed ID: 19331132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal analysis of CD4 mediated accessory function on the effector activity of human CD4+ T cell subsets.
    Lamb JR; Faith A; Higgins JA; Verhoef A; Schneider P; Yssel H; O'Hehir RE
    Clin Exp Allergy; 1995 Sep; 25(9):839-47. PubMed ID: 8564722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.